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ABSTRACT 
 
 
 
 
 
 
 
 
 
TITLE- A CLINICO-GENETIC ANALYSIS OF AUTOSOMAL 
DOMINANT SPINO CEREBELLAR ATAXIAS IN THE INDIAN 
POPULATION 
DEPARTMENT- NEUROLOGY 
NAME OF CANDIDATE- DR.KRISHNAN BALAGOPAL 
GUIDE-DR.MATHEW ALEXANDER 
 
INTRODUCTION- Spinocerebellar ataxias are neurodegenerative diseases 
characterised by progressive degrees of cerebellar ataxia along with 
ophthalmoplegia and pyramidal signs with peripheral neuropathy. There are few 
studies looking at the prevalence of various subtypes in Indian populations. This 
study aims to look at the clinical features  and do genetic testing for a 
population of familial cases of spinoocerebellar ataxia near Adigambarai village 
,Vellore and to ascertain clinic genetic co relations and also comparison with a 
hospital group of Spinocerebellar ataxia. 
 
OBJECTIVES-Neurological testing and pedigree analysis of an endemic area 
with familial cases of spinocerebellar ataxia and a  hospital population of 
spinocerebellar ataxia and to ascertain clinico genetic correlates and also 
comparison of the hospital and familial groups with respect to age of onset 
,patterns of inheritance and clinical features. 
 
METHODS- The familial group of patients near Adigambarai village, Vellore 
would be subjected to a comprehensive neurological examination and also 
detailed pedigree analysis. Genetic testing would be done for both SCA-1 and 
also SCA-2 with extraction of DNA from buccal washings. Imaging and also 
nerve conductions and evoked potentials would be done. Hospital cases  with 
positive family history presenting to CMC hospital, Vellore would also be 
looked at. The clinico genetic co relations and also  comparison of the hospital 
and the familial cases would be looked at. 
 
RESULTS-95 patients were recruited into the study of which 85 were from the 
familial group and 10 were from the hospital group.18 % of the familial group-
15 cases were clinically symptomatic while 70 of them were asymptomatic. The 
sporadic group were all symptomatic.Gait ataxia was the commonest symptom 
followed by limb inco ordination ,slurred speech, and bulbar dysfunction. 
Detailed analysis of the patterns of inheritance was done .The phenomenon of 
anticipation was seen along with the observation that paternally inherited cases  
had an earlier age of onset. Genetic testing revealed that all of the hospital cases 
as well as the 15 symptomatic cases were positive for SCA-1.Out of the 
asymptomatic cases.21 of them were genetic testing positive. Some of them had 
subtle clinical signs and need to be followed up for age of onset and clinical 
manifestations. 
               There were intra familial differences among the familial group as 
regards the age of onset and the clinical features. Comparison of the hospital 
and familial groups also revealed differences in the age of onset, severity of 
disease and also the clinical features. Imaging showed predominantly features 
of an OPCA pattern in the majority.MRS done showed features of reduced 
NAA and Choline in the pons and cerebellum. Abnormalities were also noted in 
the nerve conductions and evoked potentials. 
 
CONCLUSION: There were phenotypic heterogeneity in the  familial groups as 
well as between the hospital and familial kindreds as regards age of onset and 
clinical features. Pedigree analysis showed significant earlier age of onset for 
paternal inheritance as well as a number of asymptomatic cases who were 
genetically positive. Long term follow up of these cases is needed. 
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1. INTRODUCTION: 
 
The autosomal dominant spinocerebellar ataxias (SCAs) are a 
 
complex group of neurodegenerative disorders characterized 
 
by progressive cerebellar ataxia of gait and limbs variably 
 
associated with ophthalmoplegia, pyramidal and extrapyramidal 
 
signs, dementia, pigmentary retinopathy and peripheral 
 
neuropathy 
 
Disease onset is usually 
 
between 30 and 50 years of age, although early onset in 
 
childhood and onset in later decades after 60 years have 
 
been reported. The prognosis is variable depending on the 
 
underlying cause of the spinocerebellar ataxia subtype.  
 
Epidemiological data indicate that SCAs might be more 
 
common than that previously estimated with prevalences 
 
of up to 5–7 in 100 000 in some populations .This is similar 
 
to the prevalence of other uncommon motor neurodegenerative 
 
diseases, such as Huntington’s or motor neuron diseases. 
 
Founder mutation effects appear to contribute to the 
 
variable prevalence detected in specific SCA subtypes 
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At least 28 distinct loci are responsible for 
 
rare Mendelian forms of SCA . Interestingly, a few 
 
SCA subtypes, including SCAs 1, 2, 3, 6, 7, 17 and dentatorubral 
 
pallidoluysian atrophy (DRPLA), are caused by the 
 
expansion of a CAG (DNA sequence coding for glutamine) 
 
repeat sequence located within the coding region of specific 
 
genes, leading to an abnormally long polyglutamine (polyQ) 
 
tract in the encoded proteins named ataxins 1, 2 and 3, alpha 
 
1A-voltage-dependent calcium channel, ataxin 7, TATA box 
 
binding protein (TBP) and atrophin 1, respectively. These 
 
SCAs show, as common features, the progressive neurodegeneration 
 
of neuronal subsets in distinct brain areas 
 
and the formation of polyQ-containing protein aggregates 
 
forming characteristic nuclear or cytoplasmic inclusions 
 
. The age at onset and severity of 
 
disease symptoms inversely correlate with the length of the 
 
glutamine repeat. A second group of SCAs, including SCAs 8, 
 
10 and 12, are caused by a repeat expansion located outside of 
 
the coding region of the disease genes leading to dysregulation 
 
of gene expression 
 
Numbers for the prevalence and types of  SCA syndromes in Indian  
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populations are scattered.India is an ethnically and religiously diverse  
population.The ethnic diversity may have a bearing on the prevalence  
of the various SCA subtypes.The most common SCA type reported in 
India is SCA 2.The other SCA types reported from India are SCA1, 
SCA12 and SCA3. 
 
                             In a community that lives in certain villages around 
 Adigamparai,Vellore district, a high prevalence of SCA has been 
 observed over decades.The villages include Rajapalayam,Kottamedu and also  
Santhapalli near Vellore.This study aims to carry out genetic and  
neurological tests for SCA1 and SCA2 among this cohort.There is a  
need to do genetic testing in SCAs and obtain genotypic-phenotypic  
correlations in different ethnic populations.This would allow for  
precise classification of  the SCA subtype which in turn would help in  
genetic counselling,predictive testing ,study of natural history and 
 progression of the various subtypes of SCA.This study aims to be a  
precursor for establishing how changes at the molecular and cellular  
level lead to neurodegeneration and also help in the development of  
potential therapeutic targets. 
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2. AIMS AND OBJECTIVES 
 
1. Neurological testing and pedigree analysis of SCA patients in the 
village of Adigambarai for determining SCA subtypes based on 
phenotype and identifications of SCA subtypes in hospital cases with 
positive family history referred to CMC Vellore. 
 
2. To characterise the phenotype in detail and then ascertain the 
genotype as SCA 1 or SCA 2 and look for clinical co relations. 
 
3. To compare the hospital and the familial SCA kindreds with 
regards to the age of onset, disease severity and clinical features. 
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3. REVIEW OF 
LITERATURE 
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The term spinocerebellar ataxias (SCA) has been used to 
 
denote recessive and sporadic disorders, and 
 
neuropathologists have defined SCA as cerebellar ataxias 
 
with involvement of the spinal cord.  
 
Prevalence and incidence 
 
Epidemiological data about the prevalence of SCA are 
 
restricted to a few studies of isolated geographical regions, 
 
and most do not reflect the real occurrence of the disease. In 
 
general a prevalence of about three cases per 100 000 people 
 
is assumed, but this may be an underestimate.1,2 As SCA are 
 
highly heterogeneous, the prevalence of specific subtypes 
 
varies between different ethnic and continental populations.3  
 
Most recent data suggest that SCA3 is the 
 
commonest subtype worldwide; SCA1, SCA2, SCA6, SCA7, 
 
and SCA8 have a prevalence of over 2%, and the remaining 
 
diseases are thought to be rare (prevalence <1%).This 
 
figure has to be adjusted, as some “rare” genotypes such as 
 
SCA14 or SCA17 have not been included in previous 
 
population studies.4 Also, for gene loci that have been 
 
linked to a chromosomal region but for which the 
 
underlying gene defect has not been identified  
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epidemiological data are missing because of the lack of large 
 
families suitable for linkage analysis. The proportion of 
 
undiagnosed patients with SCA in large surveys may vary 
 
between a third (the USA, the Netherlands, Japan) and a 
 
fifth (Brazil). Founder effects—genetic bias owing to the 
 
genotypes of the founding individuals in a population— 
 
contribute to these regional differences. 
 
Genetic causes of SCA 
 
24 autosomal dominant ataxias—SCA 1–8, 10–19, 21–23, 
 
and 25, dentatorubral-pallidoluysian atrophy (DRPLA), 
 
and ataxia caused by mutations in the gene that encodes 
 
fibroblast growth factor 14 (FGF14)—have been identified. 
 
In 12 of these disorders the genes involved and the 
 
underlying mutations are known.5 Six SCA 
 
subtypes (SCA1, SCA2, SCA3, SCA6, SCA7, and SCA17) 
 
and DRPLA are caused by CAG trinucleotide repeat 
 
expansions in the respective genes. These expansions 
 
encode polyglutamine repeats, as in Huntington’s disease 
 
(HD); and these diseases are also known as polyglutamine 
 
expansion disorders. 
 
Besides CAG repeats in the coding regions, a CAG 
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repeat expansion of more than 66 repeats has been found in 
 
the 5_ region of the PPP2R2B gene11 in families with SCA12 
 
.Although the exact position of the expanded 
 
CAG repeat in the region of the PPP2R2B gene is still a 
 
matter of debate (5_ untranslated region, promoter region, 
 
or part of exon 1) it does not encode a polyglutamine tract. 
 
In SCA10, the functional implication of a 
 
pentanucleotide-repeat expansion in intron 9 of a gene of 
 
unknown function has not been defined in detail. The 
 
disease causing expansion is 800–4000 ATTCT repeats, 
 
which makes PCR based approaches for DNA testing 
 
difficult. 
 
 For SCA8, whether an unstable 
 
and expanded CTG repeat is indeed causal or only 
 
associated with the disease is still debated. 
Two autosomal dominant ataxias are caused by point 
 
mutations: mutations in FGF14 segregate with the SCA 
 
phenotype, and families with SCA14 have mutations in the 
 
gene encoding protein kinase C _, PKC_.6 
 
Repeat instability and genetic testing 
 
For SCA subtypes caused by repeat expansions, the age at 
 
onset is inversely correlated with repeat length .7,8 
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Thus small expansions are found in patients with late onset 
 
of symptoms. Small expansions that are sometimes close to 
 
the normal repeat range (SCA2, SCA6), may have reduced 
 
penetrance and may thus appear as sporadic disease without 
 
a family history.  
 
 
The expanded, longer than normal, repeats are unstable 
 
and tend to expand further. This leads to earlier age at onset 
 
and a more severe phenotype in successive generations—a 
 
phenomenon known as anticipation. Most cases of 
 
childhood onset are caused by extreme expansions between 
 
generations. For larger repeat expansions as in 
 
SCA3, somatic instability might occur making a 
 
genotype–phenotype correlation even more problematic.10 
 
Thus precise prediction for the age at onset cannot be given 
 
in presymptomatic testing. Special caution has to be taken in 
 
prenatal diagnosis owing to the instability of the repeat 
 
during transmission in particular if the father is affected. 
 
Extreme expansions in sperm have been observed for SCA7 
 
and SCA2 11 
 
Genetic counselling is similarly difficult in individuals with 
 
alleles of intermediate repeat length. These alleles are 
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unstable during meiosis and may expand into the pathological 
 
range. These repeats have expanded during evolution. Thus, 
 
fish, mice, non-human apes, and human beings have 
 
increasing repeat length in the affected genes, which is one 
 
reason why naturally occurring mouse models for repeat 
 
expansion disorders do not exist.  
 
 
Pathogenesis 
 
 
 
 
CAG repeat expansions 
 
For most types of SCA caused by CAG repeat expansion in 
 
the coding region of a gene the functions of the affected 
 
proteins are still unknown; the exceptions are SCA6, which 
 
encodes the _1A-subunit of a P/Q-type calcium channel, 
 
and SCA17, which encodes TATA-box binding protein 
 
(TBP).12,13 Except for the polyglutamine repeats, the affected 
 
proteins have no common sequences or domains. Therefore 
 
it is assumed that the pathogenesis is directly linked to the 
 
expanded polyglutamine stretch.14 Indeed, transgenic mice 
 
expressing expanded polyglutamines in a foreign protein 
 
(hypoxanthine phosphoribosyl transferase) develop a 
 
neurological phenotype and neuropathological features 
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similar to polyglutamine diseases.15 
 
Much has been learned about these disorders from the 
 
analysis of Huntington’s disease, in which polyglutamine 
 
repeats of more than 38 residues cause disease. In 1994, 
 
Perutz and colleagues15  suggested that expanded 
 
polyglutamines can form _-sheet structures and can link 
 
proteins via “polar zippers”. Huntingtin fragments 
 
containing expanded polyglutamine repeats can form 
 
insoluble aggregates in vitro whereas samples with 
 
polyglutamines at normal length remained soluble. Protein 
 
aggregates are a hallmark of all polyglutamine diseases. With 
 
a few exceptions  protein aggregates were described in 
 
neurons of affected brain regions of people with SCA27,16-18 
 
and the term neuronal intranuclear inclusion bodies became 
 
widely used in association with these disorders. In SCA2, 
 
however, aggregates are found in the nucleus and the 
 
cytoplasm, whereas in SCA6 inclusions were found only in 
 
the cytoplasm. 
 
The localisation of the polyglutamine protein within cells 
 
seems to be important: whereas ataxins normally show 
 
cytoplasmic localisation, nuclear transport might be a key 
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issue for the induction of neurodegeneration .19 
 
Furthermore, axonal transport defects might contribute to 
 
disease progression. 
 
Analysis of the composition of the nuclear inclusions 
 
uncovered that they contain only the part of the protein that 
 
contains the polyglutamine repeat. In Huntington’s 
 
disease, the protein seems to be cleaved by caspases  before 
 
being transported into the nucleus and before aggregates can 
 
be formed . Caspases, however, do not seem to 
 
have a major role in the modification of ataxins, which 
 
indicates that there are differences in the pathogenesis of 
 
different polyglutamine diseases 
 
Recent research showed that not only the polyglutamine 
 
stretch but also the remaining protein context plays an 
 
important part in the pathogenesis: in SCA1 for example, 
 
14-3-3 proteins bind to ataxin 1 after phosphorylation of a 
 
specific serine residue (S776) by Akt kinase which stabilises 
 
ataxin 1 and leads to accumulation and aggregation.20 
 
Another important mechanism in the formation of 
 
nuclear inclusions is related to the ubiquitin–proteasome 
 
pathway. Ubiquitin is used to tag proteins for disposal by 
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proteasomes. Ubiquitin, as well as several proteasomal 
 
subunits, were found in neuronal inclusions.21 The 
 
distribution of these subunits in nuclear inclusions, 
 
however, points to a perturbation of proteasomal function 
 
in patients.Several approaches highlight the importance of 
 
ubiquitin as a marker for polyglutamine-disease 
 
pathogenesis. After interruption of the ubiquitin machinery 
 
fewer inclusions are observed but neurodegeneration 
 
proceeds. The mutant proteins might be far more toxic if 
 
they are not sequestered into inclusions. The formation of 
 
inclusions could, therefore, be a protective mechanism 
 
against the toxicity of expanded polyglutamine 
 
proteins. 
 
Region-specific cell death in SCA 
 
Cell-type-specific expression patterns of mutated genes do 
 
not explain region-specific cell death in different SCA 
 
subtypes. Interacting proteins might contribute to the 
 
selectivity of the neurodegenerative process. Only for two 
 
SCA subforms, SCA1 and SCA7, have matching candidates 
 
for the region specific to neuronal cell death been identified: 
 
the Leucine-rich acidic nuclear protein, LANP, interacting 
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with ataxin 1 might explain neurodegeneration of Purkinje 
 
cells observed in patients with SCA1 and the cone–rod 
 
homeobox protein, CRX, which interacts with ataxin 7, 
 
might contribute to retinal degeneration in SCA7. 
 
Other identified interaction partners cannot explain the 
 
regional distribution but do add to our understanding of 
 
pathogenesis. For example, binding of expanded 
 
polyglutamine stretches to the polyglutamine binding 
 
protein PQBP 1 can affect transcription. Additionally, 
 
ataxin 3 interacts with cAMP response element-binding 
 
protein (CREB)-binding protein, a coactivator of many 
 
transcription factors.Polyglutamine stretches can also 
 
interact with TAFII130, another coactivator of CREBdependent 
 
transcription activation. Moreover, the CREB 
 
binding protein22  and the TATA binding protein are 
 
recruited into intranuclear inclusion bodies highlighting their 
  
relevance to the pathogenesis of 
 
spinocerebellar ataxias. Therefore, 
 
differences in expression seem to be 
 
connected in particular with CREB 
 
and TATA dependent transcription. 
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genes, disturbed protein degradation, 
 
the aggregation of proteins, disturbed 
 
transcription, altered vesicle transport, 
 
or a combination of these mechanisms 
 
trigger the death of neurons is 
 
unknown. 
 
Clinical features of ataxias 
 
SCA have a wide range of neurological symptoms including 
 
ataxia of gait, stance, and limbs, cerebellar dysarthria, 
 
oculomotor disturbances of cerebellar and supranuclear 
 
genesis, retinopathy, optic atrophy, spasticity, extrapyramidal 
 
movement disorders, peripheral neuropathy, 
 
sphincter disturbances, cognitive impairment, and epilepsy. 
 
The clinical diagnosis of specific subtypes is complicated by 
 
the huge overlap of the phenotype between genetic subtypes 
 
and substantial variability of clinical features within a 
 
distinct genetic subtype. This explains why nearly no clinical 
 
sign is specific for a genetic subtype .23,24,25 
 
 
SPINOCEREBELLAR ATAXIA TYPE 1  
 
Spinocerebellar ataxia 1 (SCAl) is an autosomal dominant disorder that is  
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clinically characterized by progressive limb and gait ataxia, dysarthria, and  
 
variable degrees of pyramidal tracts signs, brain stem symptoms, and peripheral  
 
neuropathy. 
 
The neuropathological findings in SCAl include neuronal loss in the cerebellar 
 
cortex and brain stem, as well as degeneration of the spinocerebellar 
 
tracts. The SCAl locus was the first ataxia disease locus that has been defined. 
 
Based on linkage to HLA loci, the SCAl gene was mapped to chromosome 6p 
 
26
. In 1993, Orr et al.  isolated the SCAl gene and showed that the mutation 
 
is an unstable CAG trinucleotide repeat expansion within a translated region of 
 
the gene. As in other CAG repeat disorders, the pathogenetic mechanism is not 
 
the loss of physiological function of ataxin-1, but rather the gain of a new 
 
 deleterious function 
 
Recent epidemiological studies yielded prevalence rates of dominant ataxias 
 
ranging from 0.9 :1 00,000 to 1.3: 1 00,000 27-28 The proportion of SCAl  
 
among all mutations causing dominant ataxia varies considerably among 
 
different populations. 
 
 
NEUROPATHOLOGY 
 
There is only a limited number of necropsy studies in SCAl .The findings 
 
typically involve degenerative changes, with neuonal cell loss and gliosis in the  
 
cerebellar cortex, pontine nuclei, and inferior olives, compatible with a  
 
neuropathological diagnosis of olivopontocerebellar atrophy. Often, there is  
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additional cell loss in the caudal cranial nerve nuclei, Degeneration within the  
 
basal ganglia, thalamus, and cerebral cortex are less frequent. In the spinal cord,  
 
axonal loss and pallor of myelin is observed in the dorsal column pathways, 
 
 spinocerebellar tracts, and less frequently, in the pyramidal tracts 29 
 
 Cerebellar Purkinje cells are usually most severely affected by using Golgi  
 
techniques and immunohistochemical methods, dendritic simplification with 
 
loss of spines has been described30  
 
In general, the distribution and severity of neuropathological changes in SCAl is 
 
quite variable, even within one family  
 
           Nuclear inclusions are ultrastructural hallmarks of most CAG-repeat 
 
disorders. Their significance for the pathogenesis of SCAl is discussed in the 
 
foregoing .31 Autopsy examination of one SCAl patient revealed 
 
additional neuropathological alterations, reminiscent of multiple system atrophy 
 
with demonstration of oligodendroglial cytoplasmatic inclusions 32. However, 
 
the density of these inclusions in the SCAl brain was much lower than in  
 
multiple system atrophy. 
 
V. CLINICAL FEATURES 
 
A. Disease Onset, Progression, and Survival 
 
Disease onset in SCAl varies between adolescence and late adulthood. On  
 
average,the disease starts at about the age of 35 years 33.T he earliest  
 
reported disease onset occurred in a patient from a Iakut kindred in eastern  
 
Siberia who noticed onset of ataxia at the age of 15 years . Almost all SCAl  
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patients develop first symptoms before the age of 55 years. As in other CAG  
 
repeat disorders, there is an inverse correlation between CAG repeat length and 
 
 age of onset. Anticipation has been observed in many SCAl families. 
 
SCAl always takes a progressive course, and may lead to severe disability 
 
and premature death. A recent epidemiological study reported a median latency 
 
to become wheelchair-bound after disease onset of 14 years. Median survival 
 
after onset of symptoms was 21 years, and median age at death 56 years 
 
. This result corresponds well with data from a series of 14 autopsied SCAl 
 
cases in which mean age at death was 54 years . 
 
B. Clinical Presentation 
 
All SCAl patients suffer from a progressive cerebellar syndrome, with ataxia of 
 
gait and stance, ataxia of limb movements, dysarthria, and cerebellar  
 
oculomotor abnormalities 34-36. The oculomotor abnormalities include 
 
 gaze-evoked nystagmus, saccade hypermetria, broken-up smooth pursuit,  
 
reduced optokinetic nystagmus, and impaired suppression of vestibulo-ocular 
 
 reflex by fixation 37,38. 
 
In most patients, there are additional noncerebellar symptoms. About half 
 
of the patients have supranuclear gaze palsy or saccade slowing; or both.  
 
Pyramidal tract signs with spasticity, extensor plantar responses, and  
 
hyperreflexia are found in more than 50% of patients with SCAl. In contrast,  
 
depressed or absent tendon reflexes and amyotrophy are only rarely  
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encountered. 
 
 Usually, there are no severe sensory disturbances. However, decreased  
 
vibration sense is found in up to 80% of the SCAl patients. Dysphagia is a  
 
frequent complaint of SCAl patients,and it is a particular clinical problem in late  
 
disease stages.  
 
Disturbances of sphincter control, mainly bladder dysfunction, occur less  
 
frequently, and are encountered in about 20% of the patients. Basal ganglia  
 
symptoms, with parkinsonism or dystonia have been observed only in single  
 
patients .Mental disturbances are encountered in fewer than 10% of SCAl 
 
 patients. 
 
In advanced disease stages,amnestic and cognitive deficits may occur. Some 
 
 patients develop clinically manifest dementia 39. In addition, affective  
 
disturbances, personality changes, and behavioural disorders have been 
 
 observed. 
 
These disturbances include irritability, inadaequate euphoria, aggressiveness, 
 
 and nocturnal crying 39. These clinical observations are in good accord  
 
with the results of a study in 11 SCAl patients that used standardized  
 
neuropsychological tests. This study reported deficits of verbal and nonverbal  
 
intelligence, memory dysfunction, and disturbances of executive functions.T he  
 
degree of these deficits was correlated with the severity of ataxia 40. 
 
C. Correlation of Clinical Presentation with Disease 
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           Duration and Repeat Length 
 
Clinical presentation of SCAl patients and severity of symptoms partly depends 
 
on disease duration and on the length of  the CAG repeat. Although ataxia and 
  
pyramidal tract signs are usually present in early stages of the disease, the 
 
 frequency of dysphagia, amyotrophy, hyporeflexia, sensory signs, and  
 
supranuclear gaze palsy increases with progression of the disease . A recent  
 
study from a large Siberian SCAl kindred suggested that the severity of  
 
associated symptoms, such as dysphagia, skeletal muscle atrophy, and tongue  
 
atrophy, increases with CAG repeatlength . 
 
VI. ANCILLARY TESTS 
 
A. Nerve Conduction 
 
Nerve conduction studies in SCAl patients suggest presence of mild,  
 
predominantly sensory neuropathy with features of both axonal loss and  
 
demyelination41. Motor and sensory nerve conduction velocities are in the  
 
lower-normal range. However, conduction velocities tend to be lower than in  
 
other SCA mutations,and distal latencies may be mildly prolonged . In a  
 
study of nine patients with SCAl, amplitudes of compound muscle action  
 
potentials were reduced in only one. In contrast, more than half of the patients 
 
 had low antidromic sensory nerve action potentials of the sural nerve.  
 
Needle electromyography discloses chronic neurogenic changes, but usually no  
 
pathological spontaneous activity . 
 
B. Evoked Potentials 
21 | P a g e  
 
 
Motor-evoked potentials by transcranial magnetic stimulation, are almost  
 
always abnormal in SCAl. The abnormalities include prolonged central motor 
 
 conduction time, reduced amplitudes, and raised thresholds. Visual- 
 
evoked potentials have been studied by two groups, yielding conflicting results. 
 
Schols et al. found delayed P100 responses in only one of ten SCAl  
 
patients ,whereas Abele et al reported a frequency of abnormal visual- 
 
evoked  potentialsof almost 80%. Somatosensory-evoked potentials and brain 
 
 stem auditory evoked potentials are abnormal in more than half of SCAl  
 
patients. 
 
C. Magnetic Resonance Imaging 
 
Tl-weighted magnetic resonance images (MRI) reveal global atrophy of brain 
 
structures in the posterior fossa, suggestive of olivopontocerebellar atrophy 
 
42 
                                                                                In addition, there is often  
 
visible atrophy of the cervical spinal cord . Quantitative studies, using  
 
planimetric and volumetric evaluation of MRI scans show that cerebellum,  
 
brain stem,and cervical spinal cord are, on average, shrunken to 70-80% of their  
 
normal size. These studies did not provide evidence for additional atrophy of  
 
basal ganglia nuclei . The question of whether there is also atrophy of the  
 
cerebral cortex has not yet been addressed. There are  no obvious signal 
 
 abnormalities on T2 weighted images; however, this question has not been  
 
studied systematically. 
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Magnetic resonance spectroscopy in SCA -1 
 
 
Various studies have shown the utility of magnetic resonance spectroscopy in  
 
the diagnosis of SCA-1. 
It has been found that the NAA:Creat ratios in the pons and the cerebellum were  
 
reduced as compared to normal subjects.This has been found to be an early and  
 
more sensitive change than the degree of cerebellar and brainstem atrophy seen  
 
in SCA-1.This is thought to represent a loss of neuronal viability in the  
 
brainstem and cerebellum.Also, there was a degree of correlation between the  
 
severity of ataxia and the the MRS findings in SCA1 and not in SCA 2.This  
 
may be due to the later onset and faster progression seen in SCA 1  as compared  
 
to SCA 2 . 
 
 
 
 
D. Positron Emission Tomography 
 
A positron emission tomography (PET) study in three SCAl patients, using  
 
fluorodeoxyglucose,revealed hypometabolism not only in the cerebellum and  
 
brainstem, but also in the cerebral cortex, basal ganglia, and thalamus .  
 
Because neuropathological and MRI studies do not indicate severe degeneration  
 
in these latter brain structures, hypometabolism in the cerebral cortex, basal  
 
ganglia, and thalamus is most probably due to remote effects of cerebellar and  
 
brain stem degeneration. 
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Vil. MANAGEMENT 
 
There is still no specific treatment for SCA1. Several studies suggest moderate 
 
symptomatic benefit of 5-hydroxytryptophan, amantadine, and buspirone in 
 
ataxic patients, whereas other studies were unable to confirm these findings 43,44.  
 
All studies have been performed in heterogeneous group of ataxic patients. 
 
In addition, most of the studies were only poorly controlled. There is no study 
 
that specifically addresses the question whether or not one of these compounds 
 
is particularly beneficial for SCAl patients. Spasticity in SCAl usually does not 
 
require medical treatment. 
 
Physical and speech therapy is recommended, although there are no studies 
 
providing convincing evidence that these therapies are effective in patients with 
 
progressive ataxia. Many SCAl patients are dependent on canes or wheelchairs 
 
within years after disease onset. Patients with severe dysphagia should be be fed 
 
by gastric tubing to avoid undernourishment and aspiration45 
 
 
 
STUDIES 
 
Ranum et al (1994)46 studied  the frequency and variability of the SCAI repeat 
 
expansion in 87 kindreds with diverse ethnic backgrounds 
 
and dominantly inherited ataxia. For 113 patients from the families 
  
with repeat expansion, inverse correlations between CAG repeat  
 
size and both age at onset and disease duration were observed. 
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 Repeat size accounted for 66% of the variation in age at onset in these 
 
patients. After correction for repeat size, interfamilial 
 
differences in age at onset remained significant, suggesting 
 
that additional genetic factors affect the expression of the 
 
SCA1 gene product.they  also proposed certain clinical features observed. 
 
Observed in every molecularly proved SCAl patient: 
 
Gait and limb ataxia 
 
Dysarthria 
 
Dysfunction of cranial nerves IX, X, and XII 
 
Observed in every molecularly proved SCA family but not 
 
in every SCA1 patient: 
 
Oculomotor deficits 
 
Motor weakness and amyotrophy 
 
Proprioceptive sensory deficits 
 
Pyramidal tract deficits 
 
Dystonic posturing and adventitious movements 
 
The typical clinical findings in the genetically proved 
 
SCA1 kindreds were gait and limb ataxia, dysarthria, pyramidal 
 
tract signs (spasticity, hyperreflexia, and extensor 
 
plantar responses), and variable degrees of oculomotor 
 
findings, which include one or more of the following: nystagmus, 
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slow saccades, and ophthalmoparesis. In the later 
 
stages of the disease course, bulbar findings consistent 
 
with dysfunction of cranial nerves IX, X, and XII became 
 
evident. Also, dystonic posturing and involuntary movements 
 
including choreoathetosis became apparent in the 
 
later stages of the disease. Motor weakness, amyotrophy, 
 
and mild sensory deficits manifested as proprioceptive loss 
 
were also detected. 
 
Maschke at al 2000 47 study to identify patterns of clinical features that 
 
were likely to distinguish between SCA types and to test the 
 
specificity and sensitivity of these signs and symptoms using a 
 
Bayesian classifier. In total, 127 patients from 50 families with 
 
SCA types 1 to 8 were examined using a worksheet with a 
 
panel of 33 symptoms and signs. By computing the probabilities 
 
of each trait for each SCA type, we rated the predictive 
 
value of each feature for each form of ataxia and then combined 
 
the probabilities for the entire panel of traits to construct a 
 
Bayesian classifier. Results of this analysis were summarized in 
 
a simpler, more operator-based algorithm. Patients with SCA5, 
 
SCA6, and SCA8 demonstrated a predominant cerebellar syndrome, 
 
whereas patients with SCA1, SCA2, SCA3, SCA4, and 
 
SCA7 frequently had clinical features indicating an extracerebellar 
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involvement. The Bayesian classifier predicted the SCA 
 
type in 78% of patients with sensitivities between 60 and 100% 
 
and specificities between 94 and 98.2%. The highest sensitivity 
 
to correctly predict the true SCA type was found for SCA5, 
 
SCA7, and SCA8. Sensitivities and specificities found in the 
 
present study validate the use of algorithms to help to prioritize 
 
specific SCA gene testing, which will help to reduce costs for 
 
gene testing 
 
 
 Summary of clinical features most typical for 
 
distinct SCA types 
 
Pigmentary retinopathy SCA7 
 
Pure or predominant cerebellar ataxia SCA5, SCA6, SCA8 
 
Signs of peripheral neuropathy(hyporeflexia) SCA2, SCA3, SCA4 
 
Upper motor neuron signs(hyperreflexia, spasticity) SCA1, SCA3, SCA7 
 
Ophthalmoplegia SCA1, SCA2, SCA3 
 
Myoclonus SCA1, SCA2, SCA8 
 
 
 
Chakraborty et al 200048looked at 70 cases of degenerative ataxias in an  
 
ethnic bengali population .32 of these were autosomal dominant cerebellar  
 
ataxias.genotypic analysis revealed  4 cases of SCA 2, 3 cases of SCA 3 , 1 case  
 
of SCA 1 and 2 which could not be characterised.No clear pre ponderance of  
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one particular SCA type was seen.Slow saccades and peripheral neuropathy  
 
were seen in SCA 2 phenotypes while extra pyramidal features and distal  
 
amyotrophy were seen in SCA 3 phenotypes. 
 
 
Rengaraj et al 2005 49conducted a study looking at the prevalence, clinical and  
 
molecular  genetic characteristics of  cerebellar ataxia in an ethnic Tamil  
 
community in India.An epidemiological study was done in 2 villages in Tamil  
 
Nadu where the prevalence of ataxia was high.all the people were screened and  
 
the prevalence of people with ataxia was calculated.Genetic  analysis was done 
 
 in those with ataxia and in 2 control groups.clinical and genetic results were co  
 
related.The total population screened was 378 of which cerebellar ataxia was  
 
found in 25.The mean age of onset was 39 years while the salient features were 
 
 ataxix gait(100 %),dysarthria(100%),pyramidal signs(72%),slow 
 
 saccades(48%) and bleeding diathesis(12%) 
 
Genetic testing was done in 17 of the study group of which all showed the  
 
pathogenic expansion of CAG repeats above 40 in chromosome 6p 
 
  characteristic of  SCA 1.7 asymptomatic patients in the control group also had  
 
the CAG repeat above 40. 
 
The prevalence of SCA 1 is high -7.2 % in this ethnic population with a large  
 
asymptomatic group waiting to manifest.The symptomatic individuals need 
 
 support and counselling. 
 
Krishna et al 200750 studied the  occurrence of SCA 1,2 and 3 from a south  
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Indian referral hospital in Bangalore.Probands (N=318) who were diagnosed to  
 
have an ataxia syndrome (progressive degenerative ataxia of unknown cause)  
 
attending the clinical services of the National Institute of Mental Health and  
 
Neuro Sciences (NIMHANS), Bangalore, were evaluated over a period of three 
 
years. Standard protocols were used for both clinical and molecular diagnosis. 
 
The  findings suggested SCA1 rather than SCA2 to be the more common 
 
mutation in southern India. Large numbers of SCA3 probands were also  
 
identified. Differences in prevalence of these syndromes within India need to be  
 
explored further for founder effects,correlations with phenotype, and patterns of  
 
outcome. Family history was not apparent in almost a fifth of those tested  
 
positive, highlighting the value of testing even in the absence of family history. 
 
Molecular testing should be extended to cover the other forms of ataxia, of  
 
which a large number are now known. Combined efforts to confirm the  
 
presence of these less common forms, as well as family studies to detect novel  
 
mutations, are necessary in this context in India 
 
 
 
Zulke et al51looked at CAG repeat expansions with loss of CAT interruptions in 
 
 the coding region of the ataxin-1 gene which  are associated 
 
with spinocerebellar ataxia type 1 (SCA1). For molecular genetic diagnosis it is 
 
 necessary to define the limits of normal and pathological size ranges. In most  
 
studies, normal alleles as measured by PCR range from 6 ± 39 
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units with interruptions of 1 ± 3 CAT trinucleotides that are thought to be 
 
 involved in the stability of the trinucleotide stretch during DNA replication. 
 
 Expanded alleles have been reported to carry 39 ± 81 CAG 
 
trinucleotides without stabilising CAT interruptions. To evaluate the limits  
 
between normal and disease size ranges we analysed the repeat length and  
 
composition of the SCA1 gene in 15 individuals with alleles ranging 
 
from 36 and 41 triplets for genotype-phenotype correlation studies. We found 
 
 the 39 trinucleotide-allele to be either interrupted by CAT repeats or formed by  
 
a pure CAG stretch. The clinical features of individuals carrying 39  
 
uninterrupted CAG repeats did not differ from the SCA1 phenotype in general 
 
 with dysphagia,pale discs, pyramidal signs and cerebellar tremor being more  
 
frequent as compared to other SCA genotypes.In contrast, the interrupted 39  
 
trinucleotide-allele is not correlated with the SCA1 phenotype. 
 
 
Bauer et al52 reported on a family with spinocerebellar ataxia type 1 (SCA1), in  
 
which the age at onset and the severity of the disease did not correlate with the 
 
 number of CAG repeat units. Although a marked anticipation was 
 
observed in the proband, it was not a consequence of an expansion of the CAG  
 
tract. None of the expanded alleles contained CAT interruptions. The pathologic  
 
expansion in this family was stable during the paternal but not maternal 
 
transmission, where it expanded by one trinucleotide and unexpectedly did not  
 
lead to anticipation. Our observations suggest that factors other than the length  
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of the CAG repeat play a considerable role in determination 
 
of the disease course. 
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4. MATERIALS AND METHODS 
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The patients belonging to the cohort in the village of Adigambarai  have a  
number of families ,each with multiple affected members of SCA. This is a 
 community where inbreeding is prevalent and there have been no co ordinated  
family studies. Family history, pedigree charting and also analysis form an  
important part of study for any genetic disorder. Pedigree analysis with  
molecular studies will help us determine whether the triplet expansions behave 
 differently in homozygous situations, expand from one generation to  
another(anticipation), and most importantly, do permutation alleles have any  
long term adverse effects on the individual. 
 
In this study, we will undertake charting of family trees and pedigree analysis of  
familial kindreds in 3 villages-Kottamedu initially and then Rajapalayam and  
also Santhavalli at a later stage. Kottamedu village was chosen initially as it  
falls under the purview of the Department of Community  
Health(CHAD), CMC which takes care of the medical needs of this population. 
Patients and family members would be taken for study after informed consent.  
A detailed study proforma incorporating neurological history, pedigree chart  
and neurological examination results would be structured. There would be strict  
inclusion and exclusion criteria and a detailed neurological history and  
pedigree chart would be made. 
The age of onset would be based on historical information from the patient and  
family members and the severity of the disease would be measured by the age  
of death minus the age of onset. 
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INCLUSION CRITERIA: 
 
-all patients with progressive and non progressive ataxia 
-family members at risk including first degree relatives of affected patients and  
children of the first degree relatives. 
 
EXCLUSION CRITERIA: 
 
Ataxia due to other etiology-nutritional/vitamin deficiency  
/vascular/infections/tumour 
Ingestion of toxins/heavy metals/indigenous medicines 
 
A comprehensive neurological examination would be done and ascertaining the 
involvement of domains outside the cerebellum. This would include cognition, 
 cranial nerves, motor system, extra pyramidal and peripheral nervous system.  
A detailed  pedigree chart would help in discerning the pattern of inheritance of  
the disorder. Patients at various stages of the disease, early into illness, 
established disease and advanced disease would be studied to look at the order 
 of involvement of various systems and progression of disease and effect of 
anticipation on the disorder. 
 
 Patients at various stages of the disease would be identified and MR of the 
 brain would be done to look for atrophy of the cerebellum, brainstem, cortical  
and subcortical structures. Visual evoked potentials would be done to ascertain  
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involvement of the optic nerves ,BAER to assess the involvement of the  
cochlear nerve pathways ,nerve conductions to look for involvement of 
 peripheral nerves. SSEPs would be done to look for assessment of the dorsal  
column system. A lineage analysis of the existing cases of SCA in the villages  
would be done and patients for DNA testing would be identified. Buccal  
washings of patients would be sent for genomic DNA testing on the subtypes  
SCA1  and SCA2 which would be done at NCBS, Bangalore. 
 
Sporadic cases of SCA referred to CMC Hospital would be assessed by the  
neurologist and clinical geneticist and buccal washings  would be sent to NCBS  
for genomic testing on SCA subtypes. Comparison of the sporadic and endemic  
cases would also be done. Statistical analysis was done using the students t test, 
the Mann-Whitney test and using the SPSS software. 
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5. RESULTS 
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POPULATION STUDIED AND GROUPS: 
 
The  patients in the study were divided into 2 main groups. 
 
Group 1 –consisted of patients from the cohorts of families from the affected  
Villages near Adigambarai, Vellore. This group included both patients clinically 
 affected and also other members belonging to the respective families. 
Kottamedu village was chosen for the initial phase of this study as it  
comes under the follow up and area of the community health department of  
CMC Vellore. 
 
Group 2- consisted of hospital visit  patients  with a positive family  
history  who were admitted in CMC Hospital during a period of 2008-10 with  
complaints of  unsteadiness while walking and who tested positive for SCA 1  
n genetic testing. 
 
GROUP 1  
 
There were 85 patients in this group .45 of these where male with 40 females. 
The patients  in this group were further divided into 2 more groups. Group 1a  
were  the patients who were clinically affected and were symptomatic for the  
Disease. Group b were clinically asymptomatic patients. There were 15 patients 
in group 1a and 70 in group 1 b. 
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GROUP 2 
 
There  were a total of 10 patients in this group. Of these, there were  5 males  
and 5 females. 
 
 
 
 
GROUP CHARACTERISTICS 
 
GROUP 1a-clinically affected 
 
There were 15 patients in this group-9 males and 6 females. 
The mean age at presentation was approximately  52 years. 
38 | P a g e  
The mean age of onset was around 48 years. Range-(32-68 years) 
 
The mean duration of symptoms was about 4 years. The range was from 1 to  
15 years. 
 
The severity of the disease was looked at in the affected members. This  was  
calculated by the age at present minus the age of onset of disease and also by  
clinical  examination. It was found that there were 6 patients who were mildly  
affected, 5 were moderately affected while 4 were severely affected. 
 
mild
moderate
severe
 
Group 1b-clinically unaffected 
 
The total number of patients in this group were 70 .There were 36 male patients  
and 34 females. 
 
The mean age of the patients was about 35 years-Range (6-78 years). 
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Group 2--hospital visit with positive family history 
 
A total number of 19 patients were taken who presented to the hospital with a 
family history of ataxia. Of these,10 of them genetic testing positive for SCA-1 
were recruited into this study. 
The total number of patients was 10 with 5 males and 5 females. 
The mean age at presentation was 37 years. 
 
The mean age of onset of symptoms was at 33 years with 4 years being the  
average duration of symptoms. 
 
7 of the patients had only moderate severity of ataxia with 2 severe and 1 mild  
severe. 
mild
moderate
severe
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age 
group 
Males females total symptomatic 
 
0-10 1 1 2 - 
 
10-20 10 7 17 - 
 
20-30 4 9 13 - 
 
30-40 3 4 7 2 
 
40-50 11 9 20 7 
 
50-60 9 5 14 
 
 
5 
 
60-70 2 3 5 1 
 
70-80 0 1 1 - 
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CLINICAL FEATURES 
 
GROUP 1A-CLINICALLY AFFECTED PATIENTS-FAMILIAL 
 
SYMPTOMS 
Ataxia was the commonest symptom reported among the affected patients.Out  
of the 15 affected patients,gait ataxia was reported in all 15 of them.the ataxia  
was predominantly affecting the gait in the majority of the patients.Ataxia  
affecting the limbs was seen in 8 of them in the form of limb clumsiness and  
inco ordination while truncal ataxia was seen in 6 patients. 
 
The ataxia had no diurnal variations in 12 of the 15 patients while 3 of them had  
a history of increase in symptoms in the dark and on closing the eyes ,thus  
indicating an additional sensory component. 
 
Tremors involving the limbs were seen in 8 of the patients.Of these, all 8 had  
involvement of mainly the upper limbs.The tremors were predominantly  
intention tremors which were aggravated on performing various tasks.lower  
limb tremors were not seen in any of the patients. 
 
Slurred speech was noted in 12 of the patients.This was mainly in the form of  
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Scanning and ataxia speech.There was no history of fluctuations or diurnal  
variations of the speech disturbances. 
 
 
Positive sensory symptoms in the form of tingling and numbness involving the  
lower limbs were noted in 5 of these patients.there was no history suggestive of  
sensory loss in the limbs in any of these patients.A history of cramps involving  
the extremities was elicited in 5 of these patients. 
 
COMMON SYMPTOMS 
15
8
12
6
gait ataxia
limb in coor
speech
truncal ata
 
 A  history of posturing of the limbs, both upper and lower limbs was seen in 7  
of the patients.5 of these had posturing of the upper limbs while 2 had  
involvement of the lower limbs predominantly. 
 
A history of visual disturbances was seen in 2 of the patients.Of these, 1 had a  
43 | P a g e  
history of decreased acuity while another had difficulty in seeing in the dark. 
There was no history of double vision on lateral or horizontal gaze. 
 
A history of decreased hearing in the ears was obtained in 2 of the  
patients.There was no ear pain or discharge associated. 
 
A history suggestive of  difficulty in swallowing or associated nasal  
regurgitation was obtained in 5 patients. 
 
Cognitive and behavioural changes history was obtained only in 1 patient.She  
had a history suggestive of predominantly change in behaviour in the form of  
becoming more withdrawn and apathetic  without significant memory loss or  
decline.There was no history of apraxias or hallucinations.There was also no  
history of slowness of movements or frequent falls. 
 
A history of thinning of the limbs was present in 5 of the patients with distal  
muscles involved predominantly.A history of  weakness was obtained in 3  
patients with both distal and also axial weakness being present.A history of  
tightness and heaviness involving the lower limbs was present in about 7 of the  
patients.There was no history suggestive of clonus. 
 
There was  a history of handwriting being affected in 5 of the patients.A history  
of snoring in sleep and excessive daytime somnolence was obtained in about 2  
of the patients. 
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There was no history of bladder disturbances or migraine headaches. 
Positive family history was obtained in all the affected patients. 
 
No history of drug or toxin exposure was obtained in any of the 15 patients. 
 
 
SYMPTOM CHRONOLOGY 
 
SYMPTOM                 
CHRONOLOGY  
INITIAL SYMPTOMS-WITHIN 
ONE YEAR OF ONSET  -GAIT ATAXIA 
-LIMB INCO ORDINATION 
-SLURRED SPEECH 
LATER SYMPTOMS-AFTER ONE 
YEAR OF ONSET -LIMB POSTURING 
-SENSORY SYMPTOMS 
-SWALLOWING DIFFICULTY 
 
 
SIGNS 
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General examination revealed abnormalities in many of the patients.These  
included facial hemi atrophy confined to the left half of the face seen in 2 of the  
patients.Also,short neck as defined  by the height neck ratio was present in 2  
patients. 
 
Icthyosis confined to the lower extremities was present in 2 patients.Vitiligo  
was seen in 1 of the patients.Furrowing of the forehead was seen in 8 of the  
patients with wide eyed staring look in 10 of the patients.2 of the patients had  
contractures involving the ankle joints.  
 
On examination, cardiovascular and abdominal examination revealed no  
abnormalities in any of the patients.CNS examination showed abnormal MMSE  
in the 1 patient who had cognitive dysfunction.The areas affected were frontal  
executive functions and also recall and constructional skills. 
 
Eye abnormalities were seen in patients.These included  disc pallor which was  
present in 2 patients with none of them showing retinal abnormalities. 
 
Eye movement abnormalities were seen in many of the patients.These included  
slowness of saccadic movements and also broken pursuits which were seen in  
10 of the patients.hypermetric saccades which are described in literature were  
not observed .Lateral gaze nystagmus was seen in 7 patients .Restriction of gaze  
was seen in 4 patients with upgaze more involved than downgaze. 
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Fifth nerve involvement in the form of wasting of the temporalis and masseter  
wasting was present in 11 of the 15.Bifacial weakness was also seen in 6 of the  
patients. Sensorineural hearing loss was seen in 1 patient.Palatal weakness and  
depressed gag reflex was observed in 7 patients.Most of these patients were in  
the advanced stages of the disease. 
 
Slowness of tongue movements was seen in 8 patients.5 of these had evidence  
of wasting and fasciculations involving the tongue. 
 
Thinning of the limbs was seen in 5 patients with distal wasting more  
profound.Weakness was seen in the patients.This included distal weakness in 2,  
both proximal and distal in 1 and axial weakness seen in 1 patient. 
Bipyramidal signs including spasticity and extensor plantars were seen in 9 of  
the patients. 
 
Peripheral nerve involvement in the form of large fiber neuropathy was seen in  
6 of the patients. 
 
Involuntary movements in the form of dystonia involving the extremities was  
seen in 5 of the patients.Axial dystonia was seen in 4 of the patients with  
involvement of the neck and the tongue predominant.None of the patients had  
any myoclonus or chorea. 
 
Cerebellar signs in the form of gait and limb inco ordination was seen in all 15  
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of the patients.Truncal ataxia was seen in 5 of the patients. 
 
 
GROUP 1B-CLINICALLY ASYMPTOMATIC-FAMILIAL 
 
SYMPTOMS 
 
There were 70 patients in this group.None of these patients were symptomatic  
for the disease.There was no history of gait and limb inco ordination or slurred  
speech. 
 
SIGNS 
 
General examination revealed the presence of vitiligo in 1 of the patients. 
There were no other neurocutaneous markers. 
 
Disc pallor was seen in 1 patient.Eye movement abnormalities in the form of  
slow saccades and broken pursuits were observed in  11 patients.Restricted gaze  
was seen in 1 patient. 
Temporalis and masseter wasting was present in 12 of the patients.Tongue  
wasting and fasciculations were seen in 6 patients.Bipyramidal signs were seen  
in 6 of the patients. 
 
Evidence of large fiber neuropathy in the form of depressed reflexes was seen in  
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12 patients.None of the patients had evidence of any sensory loss. 
 
Cerebellar signs in the form of mild clumsiness involving the upper limbs was  
seen in 3 patients.None of the patients had evidence of gait ataxia or truncal  
ataxia. 
Dystonic posturing involving the upper limbs was seen in 2 patients. 
2 of the patients had a history of easy bruising and also gum and abdominal  
bleeding.They were investigated for the same and found to have von  
Willebrands disease.They were on conservative treatment for the same. 
The patients had the common type 1 variant of Von Willebrands disease where 
the levels of VW factor are reduced as compared to normal. They normally 
present with increased susceptibility to bleeding after surgical procedures and 
trauma. The inheritance is autosomal dominant and linked to chromosome 
12.The linkage between SCA and Von willebrands disease has not been 
postulated and needs further research. 
 
GROUP 2-HOSPITAL VISIT CASES WITH FAMILY HISTORY 
 
SYMPTOMS 
 
Unsteadiness while walking and also slurred speech was seen in all 10 of the  
patients. 9 of them complained of tremulousness involving the upper limbs. 
None of the patients had any positive or negative sensory symptoms. 
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Thinning of the limbs and motor weakness was seen in 3 patients while  
tightness of the limbs was seen in 6 patients. 
None of the patients complained of any posturing of the limbs.None had a  
history of visual symptoms or cognitive decline 
 
SIGNS 
 
Skin changes in the form of  icthyosis was seen in 1 of the patients.hemiatrophy  
of the face seen in 2 while ankle joint contractures were seen in 1 patient. 
Disc pallor seen in only 1 patient while retinal abnormalities were seen in none  
of the patients. 
Eye movement abnormalities were seen in some of the patients. These were in  
the form of slow saccades in about 8 patients and broken pursuits in about 8  
patients. 
 
Lateral gaze nystagmus seen in 8 patients. 
 
Restriction of gaze seen in 4 patients –upgaze more than downgaze. 
Temporalis and masseter wasting seen in 4 patients. 
Bifacial weakness seen in 2 patients. 
Palatal weakness was seen in 2 patients. 
Tongue wasting and fasciculations were seen in 2 patients. 
Weakness and wasting of the limbs, predominant distal seen in 3 patients. 
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Bipyramidal signs seen in 6 patients. 
Large fiber peripheral neuropathy was seen in 4 patients. 
Cerebellar signs were seen in many patients 
Gait ataxia was seen in all 10 patients. 
Limb tremors were seen in 8 while limb inco ordination was observed in 6  
patients. 
Extrapyramidal signs were not seen in any of the patients. 
 
 
 
PEDIGREE CHARTING AND ANALYSIS 
 
Pedigree charting and analysis was done for both the sporadic and the familial  
cases. The patterns of inheritance, age of onset of symptoms and age of death of  
affected members  were looked at. Also, the differences in  the inheritance  
patterns with both maternal as well as paternal modes of inheritance were also  
studied. 
 
The familial cases were divided into a total of 16 families some of whom were  
related with a total of 85 members being studied. Some of the larger families  
had about 20 members in each for analysis. Others were part of single unrelated  
families. 
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The sporadic cases were unrelated and there were 10 different pedigrees. They  
were looked at in terms of patterns of inheritance, age of onset and also  
differences in gender of transmitting parent. 
 
ANALYSIS OF PEDIGREES 
 
-The pattern of inheritance in most of the cases was autosomal dominant. 
-The pedigrees for upto 3 generations previous to the affected patients could be  
traced. 
-The cause of death for the affected patients seemed to be mainly due to  
respiratory infections/aspiration pneumonia. 
 
-The phenomenon of anticipation was observed in many of the pedigrees  
studied. The mean age of onset of the affected patients  decreased progressively   
through succeeding generations. This ranged from 60-65 for the first generation  
affected to 40-45 for the recent generations. 
 
-The interesting point noted in analysis was that the paternally inherited cases  
had a much earlier age of onset as compared to the maternally inherited  
ones. This has been reported in literature previously. This may be due to the  
greater instability during paternal transmission as compared to the maternal  
ones. 
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 CLINICAL   
FEATURES 
EARLY-MILD TO 
MODERATE ATAXIA 
-LIMB AND GAIT ATAXIA 
-INTENTION TREMORS 
-SCANNING SPEECH 
-5TH AND 7TH NERVE 
INVOLVEMENT 
-PYRAMIDAL SIGNS 
 LATE-SEVERE ATAXIA  
-AXIAL AND APPENDICULAR 
DYSTONIA 
-PERIPHERAL NERVE 
INVOLVEMENT 
-PALATAL WEAKNESS 
 
- 
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GENETIC TESTING RESULTS 
 
 
Genetic testing was done for all the  patients in both the groups. This was done  
with DNA extraction from buccal mucosa  cells obtained by buccal  
washings. DNA amplification and gene characterization was done using PCR  
techniques. 
 
After the results of the DNA analysis, the number of trinucleotide repeats of  
certain clinically affected patients was also ascertained. This was done in order  
to calculate the co relation between the repeat size and the age of onset as well  
as the clinical severity of the affected patients. 
 
Testing was done for both the groups-the familial as well as the sporadic  
groups. The results of each were as follows. 
 
GROUP 1-FAMILIAL CASES 
 
These were again further divided into 2 groups-clinically affected and the  
clinically unaffected. 
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GROUP 1A-CLINICALLY AFFECTED AND GENETIC POSITIVE 
 
All 15 of the clinically affected patients were genetically positive for SCA-1  
mutation. Out of the 15, 13 were heterozygous for the mutation while 2 were  
homozygous for the same. 
 
The affected patients were from various families in the same locality. There  
were differences in the clinical presentation, age of onset and also severity of  
the disease in the affected members of the different families. The clinical  
features of the affected members have already been described. 
 
 
GROUP 1B-CLINICALLY ASYMPTOMATIC 
 
These were further divided again into 2 subsets. 
 
Subset 1 were those patients who were clinically asymptomatic and found to be  
carrying the genetic mutation. These members would theoretically be at risk of  
manifesting the disease at a later age in life. Some of these patients were found  
to have subtle clinical signs also, which would  be described in detail later. 
 
Subset 2 were patients who were clinically normal as well as genetic testing  
negative. 
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SUBSET 1 
 
Of the 21 patients in this subset, there were 9 males and 12 female  
patients. The mean age in this group was 35 years-range from 13 to 60 years. 
Although none of these patients were symptomatic, subtle clinical signs were  
seen in some of these patients. These included: 
 
-Eye movement abnormalities in the form of slow saccades and also broken  
pursuits were seen in 6 of these patients. However, abnormalities of the disc or  
the retina were not seen. 
 
-6 patients had evidence of temporalis and masseter wasting as was seen in  
many of the affected patients. facial weakness was not seen in any of the  
patients. 
 
-Evidence of tongue wasting and fasciculations was seen in 4 patients. 
 
-Evidence of bipyramidal involvement was seen  only in 2 patients.Peripheral  
nerve involvement  was seen in 5 patients. This was mainly large fiber  
neuropathy in the form of depressed reflexes. 
 
-Dystonic posturing of the limbs was seen in 2 patient. However, there was no  
evidence of chorea or myoclonus. 
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-Evidence of limb inco ordination in the form of mild clumsiness of the upper  
limb on finger nose finger testing was seen in 4 patients. However, none of the  
patients had evidence of gait ataxia. 
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SUBSET 2 
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Although these were the patients were clinically unaffected and also had tested   
negative for the mutation, some of them however had subtle clinical features in  
the form of  depressed reflexes, mild limb inco ordination and also temporalis  
and also masseter wasting present. 
These patients are being referred to the main hospital for further evaluation of  
underlying etiology. 
 
 
INTRAFAMILIAL DIFFERENCES 
 
 
Among the affected patients, there were members of different families all in the  
same locality .There were differences seen in the age of onset and clinical  
presentation among the various familial groups. These are highlighted below. 
 
There were 15 patients in the affected group. These were divided into various  
families living in the same region. 
 
Family 1 –largest with 7 affected members 
Family 2- 3 members affected 
Family 3- 2 members 
The remaining 3 members were the only members affected from their families. 
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DIFFERENCES 
 
1.AGE OF ONSET/INHERITANCE 
 
 There were differences between the families with regards to the age of onset  
and patterns of inheritance. 
 
Family 1 with 7 members had predominantly paternal pattern of inheritance  
.The age of onset in the first generation was in the fifth decade .However, the  
next generation had an age of onset in the fourth decade . In this case however,  
both the mother and the father were affected. This was a double dose of the  
mutation with earlier age of onset and larger numbers affected. Looking at this 
family, there were 2 cases with heterozygous inheritance and double dose of 
mutations which could account for the earlier age of onset. 
 
Family 2 had a maternal pattern of inheritance with age of onset in the fifth  
decade. 
 
Family 3 had a maternal inheritance with age of onset in the fifth decade. 
The remaining 3 members were studied for the pattern of inheritance. 
2 of the members had a maternal pattern of inheritance with a later  age of onset  
while the affected member with a paternal inheritance had an earlier age of  
onset. 
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PATIENT AGE OF ONSET-YRS INHERITANCE 
1 30 PATERNAL 
2 33 PATERNAL 
3 36 MATERNAL 
4 38 PATERNAL 
5 40 PATERNAL 
6 40 PATERNAL 
7 40 PATERNAL 
8 44 PATERNAL 
9 44 MATERNAL 
10 45 PATERNAL 
11 45 MATERNAL 
12 53 MATERNAL 
13 53 MATERNAL 
14 57 MATERNAL 
15 60 MATERNAL 
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2.CLINICAL FEATURES/SEVERITY 
 
There was no definite difference in the severity of the disease with a range from  
mild to severe disease. 
 
Regarding the clinical features, there were differences in the families. 
 
Family 1 had almost all members with a characteristic facies. This included a  
wide eyed staring look along with temporalis and masseter wasting. This was  
also seen in many asymptomatic individuals. The members with moderate to  
severe disease also had evidence of bulbar weakness. peripheral neuropathy was  
also more commonly seen in this family. 
 
Family 2 had features of tongue and limb dystonia. They also complained of  
cramps and pain in the limbs with aggravation in the night. 
 
Family 3 had one member with advanced disease who had evidence of cognitive  
dysfunction. 
 
 
 
FAMILIAL/HOSPITAL GROUP DIFFERENCES 
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1.AGE OF ONSET/INHERITANCE 
 
The average age of onset was different in the sporadic and the familial groups. 
 
The age was about 33 years in the sporadic group while it was about 43 in the  
familial group. 
The age of onset was about 10 years earlier in the sporadic group as compared  
to the familial groups. 
 
Most of the patients in the group had a moderate to severe disease. 
The 10 members in the familial group were all from different families. 
 
Looking at the patterns of inheritance, both paternal and maternal patterns of  
inheritance were seen. however, as seen in the familial group, no differences  
were seen regarding the age of onset in the paternal  and maternal inherited  
patients. 
 
2.CLINICAL FEATURES 
 
There was a higher proportion of patients who had tremor as a presenting com  
plaint in the sporadic group. Ataxia and dysarthria were seen in both groups. 
Temporalis and masseter wasting as well as the wide eyed look were less  
common in the sporadic group. 
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Disc pallor as well as lateral gaze nystagmus were seen more in the sporadic  
group as compared to the familial . 
Restriction of vertical gaze was also seen more commonly in the sporadic  
group. 
Distal weakness and pyramidal signs were more common in the sporadic group. 
 
DIFFERENCES 
DIFFERENCES SPORADIC FAMILIAL 
AGE OF ONSET 33 YRS 43 YRS 
SEVERITY MODERATE TO 
SEVERE 
MILD TO 
MODERATE 
INHERITANCE NO DIFFERENCE EARLIER ONSET 
FOR PATERNAL 
INHERITANCE 
TEMPORALIS/MASSETER 
WASTING 
NOT SEEN CHARACTERISTIC 
DISC PALLOR COMMON RARE 
GAZE EVOKED 
NYSTAGMUS 
COMMON RARE 
GAZE RESTRICTION COMMON RARE 
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INTENTION TREMORS COMMON  LESS COMMON 
PYRAMIDAL SIGNS COMMON RARE 
PERIPHERAL 
NEUROPATHY 
MORE COMMON LESS COMMON 
BULBAR DYSFUNCTION LESS SEEN MORE COMMON 
 
 
 
STATISTICAL ANALYSIS 
 
Statistical analysis was done looking for differences in the groups.. 
 
1. The patterns of inheritance and age of onset were looked at in the familial 
kindred. Comparing the maternal and paternal age of onset, it was found that 
paternally inherited cases had a significantly    lower age of onset. Mean ages-
paternal-38.75 SD-5.1 /maternal-49.71 SD-8.4 p=0.021 
2. No significant difference was seen in the types of inheritance in the hospital 
visit group.p=0.69 
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3. Difference between the homozygous and heterozygous inheritance was 
looked at and was found to be not significant-p=0.49 
4. There was a significant difference between the age of onset in the hospital 
and familial groups  .Mean 43.8-familial-SD-8.6  Hospital 32.9 SD 7.9 p=0.04   
 IMAGING FINDINGS 
 
All the patients in the sporadic group as well as some of the patients in the  
familial group underwent an imaging study-MRI of the brain. 
 
6 patients in the familial group underwent an MRI. According to the disease  
severity, the findings were as follows. 
 
2 patients with a mild disease-imaging findings showed pure cerebellar atrophy  
in 1 of the patients while the other patient showed features of OPCA with  
atrophy of the brainstem as well as the cerebellum. 
 
3 patients with moderate disease-2 showed OPCA pattern while 1 of them  
showed cerebellar atrophy. 
 
1 patient-severely affected-showed features of an OPCA pattern. 
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Among the sporadic cases, all of them had imaging done. 
 
The patient with mild disease had only cerebellar atrophy. 
 
Moderate  disease -7 patients-6 of them had OPCA pattern with 1 having  
cerebellar atrophy 
Severe disease -2 patients both had OPCA pattern on imaging. 
 
OPCA
CEREBELLAR
 
 
MRS 
 
Magnetic Resonance Spectroscopy –MRS was done in 3 of the familial cases.In  
the MRS studies done, the voxels were placed in the cerebellum and the pons  
regions which were compared with the normal areas. 
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Of the 3 cases, 1 had mild disease while the other two had evidence of moderate  
and severe disease . 
 
The patient with mild disease had no evidence of any abnormality on the MRS  
while the ones with moderate and severe disease had the characteristic features  
of decreased ratios of NAA: creat and also Choline: creat  as compared to the  
normal looking tissue. 
 
Since the number of patients was less, the significance of the above findings  
needs further studies before comment. 
 
 
CONDUCTIONS/EVOKED POTENTIALS 
 
EMG and also evoked potentials were done in some of the patients in the study. 
 
EMG STUDIES 
 
Among the familial group, EMG was done in 5 of the affected patients. 
4 of them had a normal NCV study 
1 of the patients had a mild axonal  sensory neuropathy involving the lower 
limbs 
8/10 of the sporadic patients had an NCV study done 
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6 of them had normal studies. 
 
2 of them had evidence of axonal and demyelinating motor sensory neuropathy  
involving lower limbs predominantly. 
 
 
FAMILIAL-NCV 
 
 
PATIENT SEVERITY NCV 
1 MILD NORMAL 
2 MODERATE NORMAL 
3 MODERATE MILD AXONAL 
SENSORY 
NEUROPATHY 
4 SEVERE NORMAL 
5 MILD NORMAL 
 
 
SPORADIC –NCV 
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PATIENT SEVERITY NCV 
1 MODERATE NORMAL 
2 MILD NORMAL 
3 MODERATE AXONAL AND 
DEMYELINATING 
MILD NEUROPATHY 
3 MODERATE NORMAL 
4 SEVERE AXONAL AND 
DEMYELINATING 
SEVERE 
NEUROPATHY 
5 SEVERE NORMAL 
6 MODERATE NORMAL 
7 SEVERE NORMAL 
8 MODERATE NORMAL 
 
 
EVOKED POTENTIALS 
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5 of the familial group had evoked potentials done 
2 of them had abnormal studies 
The patient with disc pallor had bilateral optic nerve dysfunction seen on the  
pattern shift VEP 
 
1 patient had evidence of dorsal cord dysfunction on the tibial SSEP.This was 
the patient who had symptoms suggestive of sensory ataxia. 
 
Among the sporadic group , 5 had evoked potentials done 
Abnormal VEP with bilateral optic nerve dysfunction seen in 1 patient 
Prolonged SSEP Tibial with dorsal cord dysfunction seen in 2 patients. 
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EVOKED POTENTIALS-FAMILIAL 
 
 
 
 
 
PATIENT SEVERITY VEP/SSEP 
1 MILD NORMAL 
2 MODERATE VEP-OPTIC N 
DYSFUNCTION 
BILATERAL 
3 MODERATE NORMAL 
4 MILD NORMAL 
5 SEVERE TIBIAL SSEP-DORSAL 
CORD DYSFUNCTION 
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SPORADIC 
 
PATIENT SEVERITY EVP/SSEP 
1 SEVERE SSEP-ABNORMAL 
2 MODERATE SSEP ABNORMAL 
3 MILD NORMAL 
4 SEVERE ABNORMAL VEP-
DISC PALLOR+ 
5 MODERATE NORMAL 
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6. DISCUSSION 
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DISCUSSION 
 
This study looked at both hospital visit as well as familial cases of SCA-1 .The  
familial  cases were from an area known to contain many affected patients with  
SCA-1 near Vellore while the hospital cases were inpatients with genetically  
confirmed SCA-1  admitted in the department of Neurology, CMC, Vellore. 
 
The familial patients were grouped into group 1 with both affected as well as  
unaffected members included. The sporadic group was classified into group 2  
with all members being affected. 
 
A total of 95 patients were studied in this project who were divided into 2  
groups. There were 85 patients in group 1 with 45 males and rest females. There  
were 15 patients among them who were clinically affected-about 18%.70 of  
them were clinically unaffected. 
 
Among the hospital group, there were 10 patients with both clinical symptoms  
and genetically proven SCA-1.both males and females were 5 each. 
 
Looking at the clinical features of the affected group of members in group 1,  
grouped into group 1a.There were 15 members-9 male and 6 female. The mean  
age of onset of symptoms was about 48 years with the mean duration of  
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symptoms being about 4 years.6 of the 15 were severely affected with 5  
members being moderately affected and 4 having only mild symptoms. 
 
Looking at the hospital group, of the 10 patients, the mean age of onset was 33  
years , with 4 years being the duration of symptoms. There is a decade earlier  
age of onset in the sporadic group as compared to the familial group. The  
majority of the patients-7 had only moderate severity of symptoms. 
 
 
CLINICAL FEATURES 
 
Looking at the clinical features in the affected group in the familial patients, it  
was found that ataxia of gait was the commonest symptom seen in all patients  
while limb and truncal ataxia were less common. intention tremors, slurred  
speech and positive sensory symptoms were the less common symptoms  
seen. The other symptoms seen were involuntary movements with posturing of  
the limbs, vision and hearing disturbances and mental status changes .Thinning  
of the limbs and a history of motor weakness were also seen in this group. 
 
 
Clinical examination revealed many findings. The main findings on general  
examination were icthyosis and also facial hemi atrophy. There was a  
characteristic wide eyed and staring look among the affected patients and also  
furrowed forehead. Another feature seen was the temporalis and masseter  
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wasting seen in almost 70 % of affected patients. 
 
Cranial nerve findings involved a number of eye findings. These included disc  
pallor in a few patients. Eye movement abnormalities included slowness of  
saccades and also broken pursuits seen in the majority of patients. Also, lateral  
gaze nystagmus and also restriction  of vertical gaze were also seen. 
 
Bifacial weakness and also bulbar and palatal weakness was seen in patients  
with advanced disease. Tongue movements slowness and also tongue  
fasciculations were seen less commonly. 
 
Evidence of bipyramidal signs were seen in about 60% of the patients. Wasting  
of the limbs and distal weakness was seen less commonly. 
 
Peripheral nerve involvement was seen in 40% of the patients. This was  
predominantly large fiber involvement. 
 
Involuntary movements were mainly in the form of dystonia. This was found to  
involve the peripheries in 33% of patients with axial dystonia seen in about  
25%.There were no patients with chorea or myoclonus. Cerebellar signs were  
seen in almost all patients. 
 
The clinically unaffected patients were 70 in number .None of them had any  
clinical symptoms. Some of the patients had evidence of subtle clinical  
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findings. These included  eye movement abnormalities seen in about 12% of  
patients.Also, temporalis and masseter wasting was observed in about 15 % of  
patients. bipyramidal signs were seen in about 13% of patients. Cerebellar signs  
and dystonic posturing were seen less commonly.2 of the patients were found to  
have  bleeding manifestations due to von Willebrands disease. The association  
between the same and SCA-1 has not been elaborated on. 
 
Coming to the sporadic cases, all 10 of them had complaints of gait and limb  
ataxia. Thinning of the limbs and also limb tightness was seen in some of the  
patients. On examination, icthyosis and also facial hemiatrophy were seen in  
about 20% of the patients. Eye signs in the form of  slow saccades and broken  
pursuits and also lateral gaze nystagmus were seen in about 70% of the patients. 
 
Bifacial weakness and palatal weakness were seen less commonly as compared  
to the familial group. Cerebellar signs were seen in all the patients. Pyramidal  
signs seen in 60% of patients while 40% of the patients had evidence of large  
fiber neuropathy. Extra pyramidal signs were not seen in any of the patients. 
 
 
PEDIGREE ANALYSIS 
 
The pedigree charting and analysis was done for both the sporadic and the  
familial groups. The patterns of inheritance as well as the age of onset and  
differences between the sporadic and the familial groups were looked at. 
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Out of the 85 familial cases, there were 10 families, some of whom were inter  
related. the sporadic cases were all from 10 unrelated families. 
 
On looking at the pedigrees, the pattern of inheritance was found to be  
autosomal dominant in keeping with the known facts about SCA-1 inheritance. 
the pedigrees included details about 3 generations . 
 
The cause of death of affected  members in previous generations seemed to be  
respiratory with bulbar dysfunction and aspiration pneumonia. 
 
There were 2 additional phenomena observed with the pedigree charting. 
The first observation was that of anticipation-the age of onset of the affected   
members were progressively decreasing in succeeding generations. This  
changed from 60-65 in the first generations to about 40-45 in the third. This is  
in keeping with the phenomena seen in trinucleotide repeat disorders. 
 
The second observation was that maternally inherited cases seemed to have a  
later age of onset while those inheriting the mutation from paternal inheritance  
were affected at an earlier age. This could be in keeping with the greater genetic  
instability during paternal transmission. This in also in keeping with earlier  
studies some of which have found the same association. 
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The clinical signs and severity of the disease were looked at. It was found that  
the cases with mild ataxia were found to have gait and limb ataxia along with  
speech disturbances and intention tremors. Pyramidal signs were also an early  
sign. the later onset signs were bulbar weakness and also peripheral dystonia. 
 
GENETIC TESTING RESULTS 
 
Genetic testing was done in both the groups. this was done using DNA extracted  
from  buccal smears. Genetic testing was done for both SCA-1 as well as SCA- 
2. The number of trinucleotide repeats in the affected patients was also looked  
at. This was done in order to look at the co relation co efficient between the  
number of repeats and the age of onset and severity of the disease. Genetic  
testing was also done to confirm the genotype of the SCA-1 sporadic cases. 
 
The testing done in group 1 showed positive results for SCA-1 in all 15 of the  
patients.13 of them were genetically heterogenous while 2 were homogenous  
for the mutation. 
 
Out of the 75 patients who were clinically unaffected, 21 of them tested positive  
for the mutation.  These were the genetic testing positive and clinically  
unaffected patients. On looking at these patients in detail, subtle clinical  
findings were found. These included the following. 
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Eye movement abnormalities seen in 25 % of these patients in the form of slow  
saccades and also broken pursuits. Temporalis and masseter wasting was also  
seen in about 25% of patients. Limb dystonia and tongue fasciculations were  
seen in only a few patients. 
 
25% of patients had evidence of  peripheral neuropathy and also evidence of  
cerebellar signs in the form of limb inco ordination. 
 
The differences between the different families was looked at. the patterns of  
inheritance were studied. It was found that the families with maternal patterns  
of inheritance had a later age of onset while those with paternal pattern of  
inheritance had an earlier age of onset comparatively. 
 
Regarding the clinical features, comparing the different families, one set of  
patients had a characteristic phenotype with temporalis and masseter wasting  
along with peripheral neuropathy and also bulbar dysfunction. The other family  
had evidence of peripheral dystonia along with positive sensory symptoms  
,predominantly nocturnal. only 1 patient had evidence of cognitive dysfunction. 
 
Comparing the differences between the hospital and the familial cases, it was  
seen that the onset of symptoms was about 10 years earlier in the sporadic group  
as compared to the famial-33 versus 43.The majority of patients in the sporadic  
group had moderate to severe disease. There were no major differences between  
the groups regarding the patterns of inheritance. 
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The sporadic cases had a higher number of patients with intention tremors, gaze  
evoked nystagmus as well as restriction of vertical gaze compared to the  
familial cases. distal weakness, peripheral neuropathy as well as disc pallor  
were also more commonly seen in the sporadic group. 
 
STATISTICAL ANALYSIS 
  
The analysis showed that there was a significant  difference in the age of onset  
in the paternal and maternal cases in the familial group but not in the sporadic 
group. This could be explained  by the greater genetic instability during paternal 
meiosis . 
There was also a significant difference between the ages of onset of familial and 
hospital cases which may be due to small numbers and also referral bias. 
No difference was made out between homozygous and heterozygous 
inheritance. 
IMAGING 
 
6 of the patients in the familial group underwent an MRI of the brain. Of  
these, 66% had features of OPCA on imaging including involvement of the  
brainstem and also the cerebellum. The rest of them, mainly the mildly and  
moderately affected patients had evidence of pure cerebellar atrophy. 
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Out of the 10 sporadic cases, 80% had features of an OPCA pattern while the  
remaining had pure cerebellar atrophy. 
Milder cases had pure cerebellar atrophy while moderate to severely affected  
cases had OPCA pattern. 
 
MRS 
 
Magnetic Resonance Spectroscopy was done in a few patients. The findings  
seen in the moderate to severely affected patients was a reduction in the  
NAA:Creat and also Choline :creat  ratios in the cerebellum and also the pons as  
compared to normal regions. 
 
 
EMG/NCV 
 
-NCV study was done in 5 of the familial cases. Of these, only 1 patient had  
evidence of a predominant sensory neuropathy involving the lower limbs. 
In the sporadic group, out of 6 patients, only 2 had evidence of a sensorimotor  
neuropathy ,both axonal and demyelinating predominantly involving the lower  
limbs. 
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EVOKED POTENTIALS 
 
-5 of the patients in the familial group had evoked potentials done.2 of these  
were abnormal.1 with bilateral optic nerve dysfunction and abnormal VEP with  
1 abnormal tibial SSEP with dorsal cord dysfunction. 
 
Of the 10 patients in the hospital group, only 3 had abnormalities.1 with an  
abnormal VEP and 2 with dorsal cord dysfunction and abnormal tibial SSEPs. 
Patients with history of sensory ataxia had electrophysiological co relate of  
abnormal SSEPs. 
 
FURTHER PLANS 
The number of trinucleotide repeats would be looked at in the affected 
individuals and co relation would be done with the severity of the disease and 
age of onset .comparisons would also be done between the familial and hospital 
groups. 
Genetic counselling would be offered to affected families. 
Occupational and physiotherapy to affected  members for enhancing the quality 
of life. 
Improvement of socio economic factors. 
Holistic care to entire community.  
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7. CONCLUSIONS 
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 This study looked at both hospital and familial cases with SCA-1.A total  
 
of 95 cases were recruited into the study. 
 
 The hospital cases were recruited from inpatients in CMC hospital,  
 
Vellore  positive for SCA-1 mutation  and were 10 in number totally. 
 The familial cases were recruited from an area endemic for SCA-1 near 
Adigambarai, vellore. There were 85 members recruited with a male 
preponderance. 
 15 of the 85 members in the familial population were clinically affected-
about 18% 
 The age of onset of symptoms in the sporadic group was about 33 years 
with 4 years being the mean duration of symptoms being about 4 years. 
The age of onset in the familial cases was about 43 years. The later age of 
onset in the familial group could be explained by the referral bias. 
 Gait ataxia was the commonest and also the first symptom noted in both 
the groups. Limb inco ordination and also slurred speech were less 
common. Bulbar symptoms and involuntary limb posturing were less 
common. 
 The clinical features of both the hospital and the familial groups were 
compared. The familial group had  certain phenotypic features 
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characteristic .These included wide eyed staring look along with evidence 
of temporalis and also masseter wasting. Certain kindreds also showed 
evidence of limb dystonia and also bulbar weakness in later stages. 
 The hospital cases showed greater incidence of intention tremors of the 
limbs along with bipyramidal signs and also eye signs including gaze 
evoked nystagmus and also restriction of vertical gaze. 
 Both groups showed features of hypometric saccades and broken pursuits 
along with evidence of peripheral neuropathy. 
 Detailed pedigree charting was done in the affected members and also 
their relatives. Certain facts were confirmed with the same. The pattern of 
inheritance was found to be autosomal dominant. The phenomenon of 
anticipation was seen with the age of onset being progressively lower in 
succeeding generations. Another feature seen was the earlier age of onset 
seen in cases with paternal inheritance. This could be explained by the 
greater genetic instability seen with paternal mutations. 
 Genetic analysis was done using buccal DNA extraction techniques.On 
analysis of the results,all 15 of the clinically affected patients in the 
familial group were positive for SCA-1 as were the 10 cases in the 
sporadic group. 
 Of the 70 asymptomatic patients in the familial group, about 21 of them 
were positive for the genetic mutation for SCA-1.some of them showed 
subtle clinical features including temporalis and masseter wasting along 
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with eye signs and also mild limb inco ordination. These patients need to 
be followed up for a longer time for noting the age of onset and clinical 
features. 
 Both intrafamilial  differences as well as differences between the hospital 
and the familial groups were seen with regards to the clinical 
features.Phenotypic heterogeneity was observed. 
 Paternally inherited cases had a significantly lesser age of onset in the 
familial group. 
 No significant difference was found in heterozygous versus homozygous 
inheritance. 
 Imaging done showed features of OPCA pattern in the majority of the 
patients with a few showing evidence of only pure cerebellar atrophy. 
The OPCA pattern was more common in those with moderate to severe 
disease with cerebellar atrophy in the milder group. 
 MR spectroscopy done showed reduced levels of NAA and also choline 
in the cerebellum and the pons. 
 NCV studies showed features of axonal and demyelinating sensorimotor 
neuropathy in patients with moderate to severe disease. 
 Abnormal VEPs and also Tibial SSEPs were also seen in a few of the 
patients with advanced disease. This was seen in patients with complaints 
of sensory ataxia thus offering an electrophysiological co relation 
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 Further studies  to look at the number of tricucleotide repeats and their 
clinical correlation with age of onset and the severity of the disease would 
be done at a later stage. 
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IMAGES 
 
 
 
 
 
 
 
 
 
 1. PATHOGENESIS OF SCA 
 
 
 
FIG-Molecular mechanisms of neurodegeneration in spinocerebellar ataxias. 1, 
aggregation; 2, apoptosis; 3, autophagy; 
4, Ca2+ homeostasis alterations; 5, disruption of axonal transport and vesicle 
trafficking; 6, excitotoxicity; 7, interference with gene 
transcription; 8, mitochondrial impairment; 9, oxidative stress; 10, alterations of 
proteasome degradation; 11, synaptic dysfunction; 
12, unfolded protein response (UPR); 13, potassium channel dysfunction; Ca2+, 
calcium ions; ER, endoplasmic reticulum; Glu, glutamate; 
K+, potassium ions; Na+, sodium ions; Q, glutamine; Ub, ubiquitin 
 
  
2.MRI  IMAGES 
 
 
 
OPCA PATTERN-atrophy of the pons and 
cerebellum-sagittal view 
  
 
 
OPCA PATTERN-brainstem and cerebellar atrophy-
axial view 
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